EUVIMEDEUVIMED entdecken
Crossref

ABCC8 Polymorphisms rs757110 and rs1801261 Association with Sulfonylurea Therapy of Iraqi Type 2 Diabetics

Sarah H Shaalan, Muneer Khudhair, Noaman Ibadi Mohammed, Zubaida Falih Alzubaidi

Wiadomości Lekarskie · 2024

DOI: 10.36740/wlek/193434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wiadomości Lekarskie, 2024. Verfasst von Sarah H Shaalan und 3 weiteren Autor:innen. Beteiligte Einrichtung: DEPATMENT OF PHARMACOGNOSY, KUFA UNIVERSITY COLLEGE OF PHARMACY, KUFA, IRAQ. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sulfonylurea Compounds, Sulfonylurea Receptors, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Our study aimed to investigate the connection between the ABCC8 gene polymorphisms (rs1801261 and rs757110) and T2DM in the Iraqi Middle Euphrates region. Patients with type 2 diabetes were chosen because they were treated with glibenclamide and glimepiride. Material and methods The groups of this case-control study are the control group obviously healthy persons included 400 (235 Male/165 Female) and 400 T2DM group (213 Male/ 187 Female). The FSG, HDL-Ch, Total-Ch, LDL-Ch, and Tgs are measured and genotyping of these two SNPs.

Results

Our findings that FSG augmented in CA and AA codominant styles of rs757110. Moreover, there were decreased insulin and BMI significantly (p = 0.002 & 0.026 respectively) in CA and AA codominant patterns of rs757110. Likewise, glucose was high significantly (0.017) and reduced insulin and BMI (p = 0.001 & 0.013 respectively) in dominant pattern (CA+AA) of rs757110. As codominant pattern (of rs757110), AA carriers revealed significant (p = 0.03) risky (OR = 1.83) when adjustment with age, BMI and sex. Additionally, after controlling for gender, age, and dominant pattern, CA + AA carriers had a significant (p = 0.02) risk factor for diabetic disease (OR = 1.45). There was no correlation between rs1801261, and T2DM.

Conclusions

The rs757110 related to less insulin excretion in T2DM of Iraqi Middle Euphrates population who received glimepiride and glibenclamide for diabetes treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Sulfonylurea CompoundsSulfonylurea ReceptorsPolymorphism, Single NucleotideHumansMaleFemaleIraqCase-Control StudiesMiddle AgedHypoglycemic AgentsAdult

Stichwörter der Autor:innen

ABCC8 genePolymorphismsType 2 diabetes mellitussulfonylurea receptors

Substanzen

Sulfonylurea CompoundsSulfonylurea ReceptorsABCC8 protein, humanHypoglycemic Agentsglimepiride

Autor:innen und Institutionen

  • DEPATMENT OF PHARMACOGNOSY, KUFA UNIVERSITY COLLEGE OF PHARMACY, KUFA, IRAQ.
  • DEPARTMENT OF LAB. INVESTIGATION, FACULTY OF SCIENCE, UNIVERSITY OF KUFA, KUFA, IRAQ.
  • DEPARTMENT OF PHYSIOLOGY, UNIVERSITY OF KUFA FACULTY OF VETERINARY MEDICINE, KUFA, IRAQ.
  • DEPARTMENT OF CLINICAL LABORATORY SCIENCES, FACULTY OF PHARMACY, UNIVERSITY OF KUFA, KUFA, IRAQ.

Zitieren

APA

Shaalan, S. H., Khudhair, M., Mohammed, N. I., & Alzubaidi, Z. F. (2024). ABCC8 Polymorphisms rs757110 and rs1801261 Association with Sulfonylurea Therapy of Iraqi Type 2 Diabetics. Wiadomości Lekarskie. https://doi.org/10.36740/wlek/193434

Vancouver

Shaalan SH, Khudhair M, Mohammed NI, Alzubaidi ZF. ABCC8 Polymorphisms rs757110 and rs1801261 Association with Sulfonylurea Therapy of Iraqi Type 2 Diabetics. Wiadomości Lekarskie. 2024. doi:10.36740/wlek/193434

BibTeX
@article{Shaalan2024,
  author = {Shaalan, Sarah H and Khudhair, Muneer and Mohammed, Noaman Ibadi and Alzubaidi, Zubaida Falih},
  title = {ABCC8 Polymorphisms rs757110 and rs1801261 Association with Sulfonylurea Therapy of Iraqi Type 2 Diabetics},
  journal = {Wiadomości Lekarskie},
  year = {2024},
  doi = {10.36740/wlek/193434}
}
Kostenlos starten →